Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Sovateltide (PMZ-1620), a first-in-class investigational product, shows promise to slow down the progression of Alzheimer's disease in patients

PR Newswire June 10, 2021

Targovax's ONCOS-102 mesothelioma 24-month data shows class-leading median overall survival

PR Newswire June 10, 2021

Soligenix Receives Pediatric Investigational Plan Waiver for HyBryte(TM) in CTCL from the European Medicines Agency

PR Newswire June 10, 2021

/C O R R E C T I O N -- Cannara Biotech Inc./

Canada NewsWire June 10, 2021

Cannara Biotech Inc. Enters into Definitive Agreement to Acquire TGOD's State-of-the-Art Cultivation and Manufacturing Facility in Valleyfield, Quebec

Canada NewsWire June 10, 2021

Chemomab Announces Poster Presentation at the International Liver Congress 2021 (EASL)

PR Newswire June 10, 2021

Cannara Biotech Enters Into Agreement to Acquire TGOD's State-of-the-art Cultivation and Manufacturing Facility in Valleyfield, Quebec

PR Newswire June 10, 2021

Theseus Pharmaceuticals Appoints Kathy Yi to Board of Directors and Chair of Audit Committee

PR Newswire June 10, 2021

Willow Biosciences and Cellular Goods Announce Multiyear Supply Agreement for Cannabigerol (CBG)

PR Newswire June 10, 2021

GO2 Foundation for Lung Cancer Expands Early Detection Efforts to Include Incidental Pulmonary Nodules (IPN) to Save More Lives

PR Newswire June 10, 2021

CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma

PR Newswire June 10, 2021

Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities

PR Newswire June 10, 2021

Immunic, Inc. to Participate in Industry and Investor Conferences in June

PR Newswire June 10, 2021

Standard Molecular Launches ConnectOTR(TM) To Clear A Path For Community Oncologists To Better Access Molecular Tests

PR Newswire June 10, 2021

Enamine implements CDD Vault to digitalize its integrated medicinal chemistry, ADME-PK and screening services

Canada NewsWire June 10, 2021

AlloSource Honors Dr. David Argo With The Annual Dr. Steven Gitelis Inspiration Award

PR Newswire June 9, 2021

DNAtrix to Present at the Raymond James Human Health Innovations Conference

PR Newswire June 9, 2021

NASA/Methuselah Challenge Winners Make History by Engineering, Sustaining Live Human Tissue in a Laboratory

PR Newswire June 9, 2021

nanoMesh(TM) LLC (a subsidiary of Exogenesis Corporation) Announces Secondary Endpoint Achieved in nanoMesh(TM) Pathogen Inhibiting Protein (PIP) Uptake Studies

PR Newswire June 9, 2021

Teams Engineer Complex Human Tissues, Win Top Prizes in NASA Challenge

PR Newswire June 9, 2021